This document provides tips for optimizing the use of PowerPoint in presentation preparation. It discusses: 1. Preparing slide presentations that are attractive, effective and informative by combining science, art, creativity and beauty. 2. Technical preparation tips for PowerPoint like using copy, paste, undo functions. 3. Identifying the tools available in PowerPoint and consistency in choosing colors, fonts, sizes for a neat appearance.

1. OPTIMALISASI PENGGUNAAN
BAHAN PRESENTASI PIMPINAN
POWERPOINT DALAM PENYIAPAN
Lydia Okva Anjelia, S.I.Kom

2. Punya banyak data, fakta, ide, dan konsep
tapi tidak tahu bagaimana cara
mengolahnya?

3. Slide Presentasi Menarik, Efektif
dan Informatif
=
Gabungan Ilmu Pengetahuan, Seni,
Kreatifitas, dan Keindahan

4. PERSIAPAN TEKNIS
Klik Kiri Klik Kanan CTRL+C = COPY CTRL+X = DELETE
CTRL+V = PASTE CTRL+Z = UNDO
TWO HANDS
Membuat powerpoint membutuhkan keterampilan tangan

5. MS. Powerpoint
TIPS 1 KENALI TOOLS YANG ADA PADA POWERPOINT

6. ELEMEN SLIDE PRESENTASI: KONTEN DAN DESAIN
TEKS/NARASI GAMBAR
IKON
SIMBOL
GRAFIK/CHART
KONTEN
TATA LETAK
(LAYOUT)

7. UKURAN DAN DIMENSI
Widescreen 16:9Ukuran Standard 4:3
Portrait
Landscape
PPT juga bisa diatur Portrait dan
digunakan dalam membuat infografis,
cover buku, laporan, dll

8. Bagaimana agar konten dalam
slide bisa tetap rapi?
KONSISTEN dalam memilih warna,
font, ukuran font, latar belakang
TIPS 1

9. TIPS 2 KEY MESSAGE
“Buat teks panjang menjadi singkat”
Sederhanakan dan batasi jumlah kata di setiap slide
Gunakan frasa kunci ditambah dengan informasi penting

10. Antimicrobial Resistance (AMR) :
Background
 In 2000-2005, dr.Soetomo Surabaya hospital
and dr.Kariadi Semarang hospital in cooperation
with KNAW (Netherlands), LUMC, MUMC,
EUMC conducted AMRIN Study: Antimicrobial
Resistance in Indonesia, and identified:
 Bacterial resistance: 9% E.coli and
K.pneumonia at the hospitals are ESBL(+)
 Antibiotic use at hospitals: 50-80%
inappropriate
 In-patient treated for more than 5 days is
exposed to resistant bacterial transmission or
experienced selective pressure mutation
process about 3-5 times
 This data is used as baseline that showed AMR
situation in Indonesia
Category
Evaluator range
Surabaya
(%)
Semarang
(%)
No indication
(treatment)
45 - 76 56 - 76
No indication
(prophylaxis)
13 - 55 43 - 76
Antibiotic
use profile

11. Antimicrobial Resistance (AMR) : Background
Category
Evaluator range
Surabaya (%) Semarang (%)
No indication
(treatment)
45 - 76 56 - 76
No indication
(prophylaxis)
13 - 55 43 - 76
Antibiotic
use profile
9%
Bacterial resistance
E.coli and K.pneumonia at
the hospitals are ESBL(+)
50-80%Inappropriate Antibiotic Use at Hospitals
is exposed to resistant bacterial
transmission or experienced selective
pressure mutation process about 3-5
times
Antimicrobial Resistance in Indonesia’s Study: dr. Soetomo Surabaya hospital and dr. Kariadi Semarang hospital in
cooperation with KNAW (Netherlands), LUMC, MUMC, EUMC conducted AMRIN (2000-2005)
This data is used as baseline that showed AMR situation in Indonesia
In-patient treated for
more than 5 days
Year 2000 - 2005

12. 40,83%
27,94%
51,69%
37,82%
26,71%
56,8%
34,31%
56,39%
45,33%
52,23%
32,16% 32,7%
0
10
20
30
40
50
60
RSDS RSSA RSDM RSDK RSSD RSP
The prevalence of ESBL producing E.coli and
Klebsiella pneumoniae among six hospitals in
Indonesia, 2013
Antimicrobial Resistance (AMR) :
Background
In 2013, Antimicrobial Resistance
Control Committe (ARCC) at
dr.Soetomo Surabaya hospital and
National Institute of Health Research
and Development (NIHRD) with WHO
support, conducted study on AMR and
AMU at 6 teaching hospitals. The study
identified as follows:
 The prevalence of E.coli and K.
pneumonia ESBL(+) reached up
to 40% (27%-56%),
 Resistance level to
cephalosporins antibiotic
generation III was 60%-100%,
and Levofloxacin was 80%-91%.

13. 40,83%
27,94%
51,69%
37,82%
26,71%
56,8%
34,31%
56,39%
45,33%
52,23%
32,16% 32,7%
RSDS RSSA RSDM RSDK RSSD RSP
Antimicrobial Resistance (AMR) : Background
40%
The Prevalence Reach up to
E.coli and K.pneumonia at
the hospitals are ESBL(+)
(27%-56%)
Resistance Level
cephalosporins
antibiotic
generation III
Levofloxacin
60%-100%
80%-91%
AMR and AMU’s Study : dr. Soetomo Surabaya hospital National Institute of Health Research and Development (NIHRD)
with WHO support at 6 Teaching Hospitals in Indonesia (2013)
Year 2013

14. TIPS 3 MENGUBAH TATA LETAK

15. Future Plan For
Strategic and Implementation of NAP
1. Coordination among Ministries, National Agency of Drug and Food Control
(NADFC) and Professional organization
2. Development of national guidelines :
a. AMU and AMR control in primary health care in human health
b. Monitoring and surveillance of AMU and AMR in human and veterinary sector
c. Laboratory referral system of AMR joined between Animal and Health sector
3. Establish a coordination by Drug Regulatory Authority (DRA) including drug
import, manufacture, quality, distribution, market authorization, advertising, and
inspection for drugs used in human health, animal health and aquaculture.
4. Research related to AMR in community, primary health care and hospitals, animal
products (poultry meat), and animal feed
5. Multisectoral budgeting

16. Future Plan for Strategic and Implementation of NAP
1 2 3 4 5
Coordination among Ministries,
National Agency of Drug and
Food Control (NADFC) and
Professional organization
Development of national guidelines :
a.AMU and AMR control in primary health care in
human health
b.Monitoring and surveillance of AMU and AMR in
human and veterinary sector
c. Laboratory referral system of AMR joined
between Animal and Health sector
Establish a coordination by Drug Regulatory Authority
(DRA) including drug import, manufacture, quality,
distribution, market authorization, advertising, and
inspection for drugs used in human health, animal
health and aquaculture.
Research related to AMR in
community, primary health care and
hospitals, animal products (poultry
meat), and animal feed
Multisector budgeting

17. TIPS 4: GRAFIK/CHART YANG EDITABLE

18. Three Variables
Two
Variables
Many
Points
Few
Points
Single
Variable
DISTRIBUTION
Two
Variables
Three Variables
RELATIONSHIP
Static over time
Simple
Share of Total
Accumulation
Subst. of Total
Components of Components
Change over
time
Relative Difference
Relative and Absolut
Difference
Few Periods – Relative Difference
Many
Periods
Few Periods – Relative and Absolut Difference
COMPOSITION
Cyclical DataNon-Cyclical Data
Few CategoriesMany Categories
Over Time
Many
Periods
Few
Periods
Many Categories
Two Variables
Many Items Few Items
Among Items
Few
Categories
Many
Categories
COMPARISON
What would
you like to
show?
Sumber: slidemodel.com
JENIS-JENIS GRAFIK (CHART)

19. Paripurna
43%
Utama
8%
Madya
5%
Dasar
2%
Perdana
42%
Status Akreditasi RS
1.607 dari 2825 RS Terakreditasi
Paripurna 688
Utama 124
Madya 82
Dasar 38
Perdana 675
Data : Web KARS 24 Oktober 2018
95%
3% 2%
RS KELAS A
Paripurna
Utama
Madya
Dasar
Perdana 87%
6%
4%
3%
0%
RS KELAS B
Paripurna
Utama
Madya
Dasar
Perdana
37%
9%
5%3%
46%
RS KELAS C
Paripurna
Utama
Madya
Dasar
Perdana
10%
5%
7%
2%
76%
RS KELAS D
Paripurna
Utama
Madya
Dasar
Perdana
CAPAIAN MUTU RUMAH SAKIT MELALUI AKREDITASI

20. Upaya KEMENKES
mencapai
PERLUASAN CAKUPAN KEPESERTAAN
MENUJU #UHC2019
8.7 57.8 65.4 75.3 83.8
95.1
98.9 106.4 112.6 119.6
2014 2015 2016 2017 S/d Okt 2018
Non-PBI PBI
133,4
Juta Jiwa
156,7
Juta Jiwa
171,9
Juta Jiwa
187,9
Juta Jiwa
203,2
Juta Jiwa
Penduduk Indonesia telah
menjadi peserta JKN
2018
2019
203.284.896 257,7
JUTA
JIWA
18437
19969
20708
21736
22648
2014
2015
2016
2017
2018
1681
1847
2069
2292
2443
2014
2015
2016
2017
2018
Fasilitas Kesehatan Rujukan Tingkat LanjutFasilitas Kesehatan Tingkat Pertama
Sumber: Laporan BPJS Kesehatan S/d Oktober 2018
Pemanfaatan Pelayanan (Jumlah Kunjungan)
2014 2015 2016 2017 s/d Juli 2018
92,3 JUTA 146,7 JUTA
192,9 JUTA
233,4 JUTA
130,9 JUTA

21. PENINGKATAN AKSES DAN MUTU FASILITAS KESEHATAN
53%
Terakreditasi
56,7% RS
Terakreditasi
Perkembangan Jumlah Puskesmas di Indonesia
2015 - 2018
Perkembangan Jumlah Rumah Sakit di Indonesia
2015 – 2018
(Data per 1 Oktober 2018)
Pembangunan
Puskesmas di DTPK
Tahun 2017 - 2018
Pembangunan 3 RS Vertikal di
Kawasan Timur Indonesia
(RS di Ambon Maluku Tahun 2018)
2488
2601
2732
2821
2015 2016 2017 2018
110
256
2017 2018
9758 9767
9825
9909
2015 2016 2017 2018
Pembangunan RS
Pratama
22
34
51
24
27
50
60
2015 2016 2017 2018
CAPAIAN TARGET
Jumlah Kumulatif

22. Gunakan fitur master slide untuk
membuat template desain yang
konsisten dan memudahkan
pembuat presentasi dalam
memasukan konten dan
membuat presentasi lainnya
GUNAKAN FITUR MASTER SLIDE UNTUK MEMBUAT TEMPLATE

23. https://freepik.com
https://pixabay.com/
https://www.pexels.com/
http://www.sitebuilderreport.com/stock-up
https://stocksnap.io/
https://pablo.buffer.com/
SUMBER GAMBAR

24. https://pinterest.com/
https://slidemodel.com/
https://creativemarket.com
https://envatomarket.com
SUMBER IDE

25. TERIMA KASIH
www.okvaa.wordpress.com fb.com/lydiaanjelia @okva@okva